Prehabilitation in an Integrative Medicine Day Clinic for Patients Undergoing Neoadjuvant Treatment: Single-Center Feasibility Pilot Study

被引:2
|
作者
Raff, Christian [1 ]
Doerr-Harim, Colette [2 ]
Otto, Stephanie [3 ]
Thiele, Johanna [1 ]
Mihaljevic, Andre [4 ]
Kramer, Klaus [1 ]
机构
[1] Univ Hosp Ulm, Dept Gen & Visceral Surg, Working Grp Integrat Med, Albert Einstein Allee 23, D-89081 Ulm, Germany
[2] Heidelberg Univ Hosp, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany
[3] Univ Hosp Ulm, Comprehens Canc Ctr Ulm, Ulm, Germany
[4] Univ Hosp Tubingen, Dept Gen Visceral & Transplantat Surg, Tubingen, Germany
来源
JMIR RESEARCH PROTOCOLS | 2023年 / 12卷
关键词
supportive care; prehabilitation; neoadjuvant treatment; integrative medicine; multimodal prehabilitation; cancer; oncology; surgery; preoperative; feasibility; integrative; naturopathy; naturopathic; diet; nutrition; SURGERY; RECOVERY; QUALITY;
D O I
10.2196/46765
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Patients with cancer receiving neoadjuvant treatment prior to surgery are in a very stressful situation. Chemotherapy and radiation therapy put a strain on the quality of life and the pending surgery poses a relevant burden for many patients. Preparation of these patients for the intervention in terms of prehabilitation has great potential to reduce the burden of postoperative complications and may improve the clinical outcome. A prehabilitation approach also yields the possibility to address unmet patients' needs and to help them modify their lifestyle in a maintainable way. Therefore, a multimodal approach is mandatory during this critical period. Objective: The aim of this study is to assess the feasibility of prehabilitation in an integrative medicine day clinic (PRIME-DC) prior to cancer surgery at a major university clinic. PRIME-DC is considered feasible if 80% of enrolled patients are willing and able to complete at least 6 out of the 8 weekly meetings, each lasting 6.5 hours, at such a clinic. Secondary end points aim to evaluate this multimodal program.Methods: The PRIME-DC intervention combines mind-body medicine, exercise therapy, nutrition therapy, naturopathic counseling, and the application of a yarrow liver compress. Adult patients with cancer, with a primary tumor in the abdomen (including intraperitoneal cancer, stomach cancer, and extraperitoneal cancers such as pancreatic, bladder, rectal, esophageal, endometrial, ovarian, and cervical cancer) or the breast requiring a neoadjuvant oncological treatment setting are eligible to participate. The addressed cancer entities imply either an extensive surgical intervention with an expected need for prehabilitation (eg, abdominal surgery) or a neoadjuvant treatment of several months with a high burden of treatment-associated side effects (breast cancer). Adherence to the day clinic program is the primary end point being defined as presence during the day clinic session. Secondary end points are physical assessment and quality of life, together with a structured assessment of neoadjuvant treatment-associated side effects. Furthermore, to collect qualitative data voluntary participants of the day clinic will be interviewed in a semistructured way after completion of the day clinic program on each component of the study (mind-body intervention, exercise, nutrition, naturopathic counseling, and a yarrow liver compress). Results: The procedures used in this study adhere to the tenets of the Declaration of Helsinki. As of February 2023, we enrolled 23 patients; the dominant cancer entity is breast cancer (18 enrolled patients). Conclusions: The presented protocol combines prehabilitation, lifestyle modification, naturopathic counseling, dietary assistance, and naturopathic treatment in an innovative and integrative way.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Prehabilitation in an integrative medicine day clinic (PRIME-DC) for patients undergoing neoadjuvant treatment: a single-center feasibility study
    Otto, S.
    Raff, C.
    Doerr-Harim, C.
    Thiele, J.
    Mihaljevic, A.
    Kramer, K.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 (SUPPL 3) : 4 - 4
  • [2] Feasibility of breath monitoring in patients undergoing elective colonoscopy under propofol sedation: A single-center pilot study
    Anand, Gurpreet W.
    Heuss, Ludwig T.
    WORLD JOURNAL OF GASTROINTESTINAL ENDOSCOPY, 2014, 6 (03): : 82 - 87
  • [3] The feasibility of individualized prehabilitation for patients undergoing gastrointestinal cancer resections: a pilot study
    Bingener-Casey, Juliane
    Bauer, Brent A.
    Cutshall, Susanne M.
    Skaran, Pamela E.
    Cheville, Andrea L.
    Sloan, Jeff A.
    MINERVA CHIRURGICA, 2019, 74 (01) : 112 - 113
  • [4] PREHABILITATION FOR PATIENTS UNDERGOING CYSTECTOMY: PRELIMINARY ANALYSIS OF A SINGLE-CENTER, RANDOMIZED CONTROLLED TRIAL
    Kassouf, Wassim
    Minnella, Enrico
    Awasthi, Ramon
    Ferreira, Vanessa
    Aprikian, Armen
    Tanguay, Simon
    Carli, Franco
    JOURNAL OF UROLOGY, 2018, 199 (04): : E622 - E622
  • [5] Exercise prehabilitation program for patients under neoadjuvant treatment for rectal cancer: A pilot study
    Alejo, Lidia B.
    Pagola-Aldazabal, Itziar
    Fiuza-Luces, Carmen
    Huerga, Daniel
    Victoria de Torres, Maria
    Soria Verdugo, Ana
    Ortega Solano, Maria Jesus
    Luis Felipe, Jos
    Lucia, Alejandro
    Ruiz-Casado, Ana
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2019, 15 (01) : 20 - 25
  • [6] Feasibility, tolerability, and effects of exercise-based prehabilitation after neoadjuvant therapy in esophagogastric cancer patients undergoing surgery: an interventional pilot study
    Argudo, Nuria
    Rodo-Pin, Anna
    Martinez-Llorens, Juana
    Marco, Ester
    Visa, Laura
    Messaggi-Sartor, Monique
    Balana-Corbero, Anna
    Ramon, Jose M.
    Rodriguez-Chiaradia, Diego A.
    Grande, Luis
    Pera, Manuel
    DISEASES OF THE ESOPHAGUS, 2021, 34 (04)
  • [7] Feasibility of a Multimodal Prehabilitation Programme in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian Cancer: A Pilot Study
    Diaz-Feijoo, Berta
    Agusti-Garcia, Nuria
    Sebio, Raquel
    Lopez-Hernandez, Antonio
    Siso, Marina
    Glickman, Ariel
    Carreras-Dieguez, Nuria
    Fuste, Pere
    Marina, Tiermes
    Martinez-Egea, Judit
    Aguilera, Laura
    Perdomo, Juan
    Pelaez, Amaia
    Lopez-Baamonde, Manuel
    Navarro-Ripoll, Ricard
    Gimeno, Elena
    Campero, Betina
    Torne, Aureli
    Martinez-Palli, Graciela
    Arguis, Maria J.
    CANCERS, 2022, 14 (07)
  • [8] Prehabilitation-A Simple Approach for Complex Patients: The Results of a Single-Center Study on Prehabilitation in Patients with Ovarian Cancer Before Cytoreductive Surgery
    Zebalski, Marcin Adam
    Krzywon, Aleksandra
    Nowosielski, Krzysztof
    CANCERS, 2024, 16 (23)
  • [9] Digital follow-up program for patients undergoing atrial fibrillation ablation: a pilot single-center study
    Brandao, M.
    Teixeira, R.
    Goncalves Almeida, J.
    Fonseca, P.
    Mosalina Manuel, A.
    Ramires, F.
    Ferreira, P.
    Sousa, M.
    Oliveira, M.
    Goncalves, H.
    Primo, J.
    Fontes-Carvalho, R.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [10] Therapeutic Drug Monitoring of Busulfan in Patients Undergoing Hematopoietic Cell Transplantation: A Pilot Single-Center Study in Taiwan
    Chen, Rong-Long
    Fang, Li-Hua
    Yang, Xin-Yi
    El Amrani, Mohsin
    Uijtendaal, Esther Veronique
    Chen, Yen-Fu
    Ku, Wei-Chi
    PHARMACEUTICALS, 2021, 14 (07)